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FTC May Determine Whether Advertisements 
Containing Therapeutic Claims in Promotion 
of Health Books Are Deceptive-
Rodale Press, Inc.* 
1499 
Rodale Press advertised that the ideas and suggestions in its 
publication, The Health Finder, would increase life span, prevent 
various diseases, and permit savings on medical and dental expenses. 
The Federal Trade Commission challenged the advertising claims, 
which were substantially restatements of claims made in the book, 
on the ground that adherence to the book's suggestions would not 
effect the promised results. The hearing examiner denied Rodale's 
motion to dismiss the complaint. On request for permission to file 
an interlocutory appeal from the dismissal, held, request denied, 
one commissioner dissenting.1 The Commission may challenge the 
collateral claims in the advertising of a health book as false and 
deceptive.2 
• TRADE REG. REP. (Transfer Binder 1963-65) ,r 16864 (ITC 1964) (complaint) 
&: id., ,r 17149 (ITC 1964) (order denying request for permission to file an inter-
locutory appeal) (pending). 
I. Commissioner Elman dissented. See notes 10, 21 infra. While the principal 
attack is on The Health Finder, the Commission has also challenged the advertising 
of two pamphlets, How To Eat for a Healthy Heart and This Pace Is Not Killing Us, 
published and distributed by Rodale Press. See TRADE REG. REP. (Transfer Binder 
1963-65) 1f 16864 (ITC 1964) (complaint). The Health Finder is no longer in general 
circulation and the two pamphlets are out of print. Advertisements for all three 
publications have been long discontinued. There may be some question, therefore, 
whether the requisite "public interest" still exists. However, the Commission has 
wide latitude in determining the "public interest." Standard Distributors, Inc. v. FTC, 
211 F.2d 7, 13 (2d Cir. 1954). Moreover, discontinuance of allegedly unfair trade 
practices does not necessarily make the proceeding moot, because the practices might 
revive. See FTC v. Goodyear Tire&: Rubber Co., 304 U.S. 257, 260 (1938) (per curiam). 
2. See Address by Charles A. Sweeney, Chief of the Division of Food and Drug 
Advertising of the FTC, National Congress on Medical Quackery, 5 TRADE REG. REP. 
1[ 50207 (1963): 
"[T]he Commission's interest in advertising for medical books is continuing. It 
should be made clear in these cases the Constitutional guarantees of free speech 
and free press preclude the Commission from censoring the content of a book. 
The Commission does, however, assert jurisdiction over advertising for the 
book. Thus, if an author expounds his theories for the treatment and cure of 
arthritis, the Commission does not attempt to stop the sale of the book or the 
expressions of opinion contained therein. But the collateral claims, in advertising, 
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Although the Federal Trade Commission has campaigned mainly 
against deceptive advertising of drugs and related human consump-
tion commodities in the therapeutic field,3 it has instituted several 
proceedings against health book publishers in recent years.4 The 
Commission's authority to proscribe misrepresentations of the au-
thor's or seller's qualifications is well established.6 It is also clear 
that the Commission can prohibit misrepresentations of a book's 
actual content.6 But the Commission's power to enjoin the advertis-
ing of the merits of a health book has not been clearly defined. In 
Witkower Press, Inc.,7 under facts similar to Rodale Press, the Com-
mission issued an order forbidding advertisements which represented 
that the book offered an effective or reliable cure for arthritis, even 
though the advertisements asserting the claims were taken almost 
verbatim from passages in the book. Although the Commission's 
authority was there questioned, 8 the final order was never appealed. 
Legislative history of the Federal Trade Commission Act9 indicates 
that Congress meant to reach every form of advertising deception.10 
Nevertheless, it has been argued by some that Congress did not 
intend the act to impede the dissemination of·ideas, whatever their 
validity, 11 and that advertisements repeating the ideas in books are 
not within the purview of the statute.12 
that the information and instructions contained in the book will enable a reader 
to cure his arthritis are subject to challenge and, if false, violate the Federal 
Trade Commission Act." 
3. See address by Charles A. Sweeney, supra note 2. The consumer, particularly the 
infirm consumer, is especially vulnerable to advertisements of therapeutic claims 
because he cannot evaluate medical representations. Deceptive medicinal advertise-
ments are a matter of -utmost public concern. See Barnes, False Advertising, 23 Omo 
ST. L.J. 597, 633-35 (1962). 
4. E.g., Witkower Press, Inc., 57 F.T.C. 145 (1960); Farrar, Straus &: Cudahy, Inc., 
TRADE REG. REP. (Transfer Binder 1963-65) 11 16518 (FTC 1963) (complaint), id., 
t 16866 (FTC 1964) (order to cease and desist); Simon &: Schuster, Inc., TRADE REG. 
REP. (Transfer Binder 1963-65) 11 16559 (FTC 1963) (complaint); Rodale Press, Inc., 
TRADE REG. REP. (Transfer Binder 1963-65) 1[ 16864 (FTC 1964) (complaint) &: id. 
1] 17149 (FTC 1964) (order denying request for permission to file an interlocutory 
appeal) (pending). 
5. See FTC v. Standard Educ. Soc'y, 302 U.S. 112, 118 (1937). In Witkower Press, 
Inc., supra note 4, the Commission enjoined the use of "Ph.D." after the author's name 
when the degree was shown to be phony. 
6. See Bantam Books, Inc. v. FTC, 275 F.2d 680 (2d Cir. 1960) (fact of abridgement 
must be clearly set forth); Standard Distribs., Inc. v. FTC, 211 F.2d 7 (2d Cir. 1954) 
(false representation that encyclopedia was a new edition). Similarly, the advertise-
ment cannot misrepresent the material covered in a book. Cf. Trade Practice Con• 
ference Rules, 16 C.F.R. §§ 150.00-.22 (1960) (pertaining to the subscription and mail 
order publishing industry). 
7. 57 F.T.C. 145 (1960). 
8. Id. at 218-19. 
9. 52 Stat. Ill (1938), 15 U.S.C. §§ 41-77 (1958). 
10. See H.R. REP. No. 1613, 75th Cong., 1st Sess. 5 (1937). 
11. In dissent, Commissioner Elman expressed the view that the complaint was 
beyond the Commission's statutory authorization. TRADE REG. REP. (Transfer Binder 
1963-65) 11 17149, at 22232-33 (FTC 1964). 
12. See Scientific Mfg. Co. v. FTC, 124 F.2d 640, 644 (3d Cir. 1941). Of course, 
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The main problem in construing the Federal Trade Commission 
Act to cover the Rodale Press situation is that such an interpretation 
may bring the statute into conflict with the first amendment.13 In 
order to prove its allegations that advertising for the Health Finder 
is deceptive,14 the Commission must establish that the medical advice 
in the book does not produce the results claimed in the advertising. 
Since the advertising claims are substantially the same as those made 
in the book, the Commission must examine the validity of the 
theories expounded by the author, that is, the medical value of the 
book's ideas.15 In defense, Rodale Press must support the book's 
ideas. On every occasion when the Commission has attempted to ban 
the ultimate distribution of books with no proved medical value it 
has been reversed by the courts on the alternative grounds that it 
exceeded its statutory authority or that it abridged the freedom of the 
press.16 Consequently, it now seems clear that the Commission cannot 
impede a book's publication;17 and the indispensability of adver-
tising to effective distribution has been judicially recognized.18 Since 
a publisher has a first amendment right to launch a book into the 
marketplace of ideas, it would seem to follow that he has a right to 
promote its circulation by advertising the ideas expressed in the 
book. 
Protecting the right to advertise the book's ideas presents a 
problem, however, that is not encountered in protecting the book 
itself from censorship. When taken from the context of the book and 
placed into advertisements, the ideas may assume the character of 
if the publication itself is in reality a deceptive advertisement for another commodity, 
its dissemination can be enjoined. See Koch v. FTC, 206 F.2d 311 (6th Cir. 1953); 
Penna-Maid Co. v. FTC, 121 F.2d 282 (6th Cir. 1941). 
13. A first amendment objection was raised but held to be without merit by the 
Commission in Witkower Press, Inc., 57 F.T.C. 145, 218-19 (1960). It is generally 
acknowledged that a manufacturer of products for consumption has no constitu• 
tional right to disseminate false and misleading advertisements concerning them. 
Regina Corp. v. FTC, 322 F.2d 765, 770 (3d Cir. 1963); Murray Space Shoe Corp. v. 
FTC, 304 F.2d 270, 272 (2d Cir. 1962); E. F. Drew&: Co. v. FTC, 235 F.2d 735, 739-40 
(2d Cir. 1956); United States v. Nutrition Serv., Inc., 227 F.Supp. 375 (W.D. Pa. 1964). 
In E. F. Drew &: Co., supra, the court declined the Commission's invitation to state 
categorically that no advertisement was protected by the first amendment. 
14. In Rodale Press, paragraph seven of the complaint states "In truth and in 
fact: I. The ideas and suggestions contained in 'The Health Finder' will not assure 
readers: (a) An increased life span ..•. " TRADE REG. REP. (Transfer Binder 1963-65) 
~ 17149, at 22232 n.l (FTC 1964). 
15. Cf. Koch v. FTC, 206 F.2d 311, 317 (6th Cir. 1953). 
16. Ibid.; Scientific Mfg. Co. v. FTC, 124 F.2d 640 (3d Cir. 1941). 
17. The Supreme Court has emphasized that liberty of circulating is as funda• 
mental as liberty of publishing. See Lovell v. City of Griffin, 303 U.S. 444, 452 
(1938). In Smith v. California, 361 U.S. 147, 150 (1959), the Court stated: "And it 
also requires no elaboration that the free publication and dissemination of books 
and other forms of the printed word furnish very familiar applications [of liberty 
of the press and of speech]. It is of course no matter that the dissemination takes 
place under commercial auspices." 
18. See Ford Motor Co. v. FTC, 120 F.2d 175, 183 (6th Cir. 1941). 
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accepted medical truths. Apparently, the Commission's view is that 
such advertisements may be deceptive and are thus subject to chal-
lenge,19 even though the book itself is opinion and protected by 
the first amendment. Presumably no deception occurs if the adver-
tisement shows the claims to be the author's theories and opinions. 
However, the Commission 'has never defined a standard for distin-
guishing between nondeceptive and deceptive advertising of an 
author's ideas.20 Indeed, such a distinction, if not spurious, would 
at least be quite difficult to maintain.21 For example, suppose an 
advertisement reads: "This book will effectively reduce your weight 
from six to fifteen pounds monthly. No calorie counting, no exer-
cises, just happy eating." Even had these words also appeared in the 
book's foreword, they may in fact be deceptive because in the context 
of the advertisement, the word "effectively" tends to elevate the 
author's opinion to the plane of proved scientific fact. But if it is 
recited only in the book, it is clearly not subject to challenge. If the 
statement in the advertisement were clearly and prominently identi-
fied as a quotation from the book, it would presumably be considered 
nondeceptive in the Commission's view and, in any event, should 
be protected by the first amendment.22 A more difficult case would 
be presented, however, if the advertisement presented above con-
cluded: "Read the author's ideas and suggestions in this book." 
Arguably, the advertisement is not deceptive, because it suggests 
19. See address by Sweeney, supra note 2. In the motion to dismiss, counsel for 
Rodale Press stated: "[The Commission's] counsel appear to take the position that 
the medical opinions expressed in the book are matters of opinion and not within 
the jurisdiction of the Commission to challenge. But the same opinions used in 
advertising the book cease to become opinions; they suddenly become statements of 
fact which counsel may be ordered to desist from making." Respondents' Motions To 
Dismiss the Complaint or in the Alternative To Certify the Questions Presented to 
the Federal Trade Commission, p. 16, Rodale Press, Inc., F.T.C. Doc. No. 8619 
(pending). 
20. If the publisher overstates what even the author purports to say, the Commis• 
sion need not examine the validity of the ideas expressed in the book. See note 6 supra, 
and accompanying text. The Commission then simply compares the advertisement 
with the contents of the book to determine whether a material variance exists. 
21. Commissioner Elman in dissent constructed this hypothetical case: "Suppose 
someone were to write a book advancing the theory that ills of our body politic 
would be cured if only the United States Senate were abolished. Could this Com• 
mission enjoin advertising for the book by finding that abolishing the Senate is not 
an 'effective' cure for such ills? Surely not. Congress did not create this Commission 
to act as a censor of unorthodox ideas and theories in books, whether they deal with 
politics or health. We should not forget that, in both fields, today's heresy may 
become tomorrow's dogma." Rodale Press, Inc., F.T.C. Dkt. 8619, TRADE REc. REP. 
(Transfer Binder 1963-65) 1J 17149, at 22233 (FTC 1964) (order denying request for 
permission to file an interlocutory appeal) (pending). In Respondents' Motions To 
Dismiss the Complaint or in the Alternative To Certify the Questions Presented to 
the Federal Trade Commission, p. 18, counsel for Rodale Press questioned "whether 
'Science and Health with a Key to the Scriptures' by Mary Baker Eddy could be 
advertised by Christian Scientists as having therapeutic value. Is it the duty of the 
Commission to examine medical experts and after establishing that the therapeutic 
value of Christian Science is in conflict with the universal expert opinion of doctors, 
to prevent the advertising of Mary Baker Eddy's book?" 
22. See notes 16-18 supra and accompanying text. 
June 1965] Recent Developments 1503 
to the prospective buyer that the value of the book lies in the ideas 
expressed by its author. On the other hand, the word "effectively" 
may still create an impression of proved fact in the mind of the 
reader of the advertisement, even though it is only the author who 
believes that his ideas are "effective." 
How much clarity the FTC will demand in requiring book adver-
tisements to show that only the author's opinion is involved is un-
certain. It seems doubtful that any consistent standard that could 
serve as a guide to publishers or their advertisers could be developed, 
except for the extreme cases. 'I1he confusion in attempting to formu-
late a standard is further underscored if the author or publisher in-
corporates in the book's title a claim which the Commission considers 
deceptive. In Rodale Press, counsel for the Commission conceded 
that if The Health Finder were entitled How To Live Longer and 
Feel Better, which is a phrase taken substantially from the book, 
the Commission could not en join the use of the title.23 Yet the title 
serves an advertising function, and it is not unrealistic to assume 
that an author or a publisher will frequently select a title with that 
in mind.24 
Until a standard capable of consistent legal application is de-
veloped, therefore, it seems that first amendment protection 
should extend to all book advertising repeating substantially ideas 
expressed in a book.25 Even if a standard evolves, the serious ques-
tion remains whether the Commission was intended to proceed 
under the Federal Trade Commission Act against book promotional 
advertising which merely repeats the ideas expressed by an author. 
Unlike a manufacturer of products for physical consumption, a 
publisher is attempting to sell ideas and opinions. In order to market 
a book successfully, its publisher needs to be able to bring before 
the public statements made by the author, including the author's 
conclusions about the value of his ideas. Unless the publisher mis-
represents the book's purpose, scope, or actual content,26 it is diffi-
cult to justify any FTC restriction on his advertising pronouncement 
that raises such significant constitutional questions. 
23. See Respondents' Motions To Dismiss the Complaint or in the Alternative To 
Certify the Questions Presented to the Federal Trade Commission, p. 17, Rodale 
Press, Inc., F.T.C. Doc. No. 8619 (pending). 
24. Calories Don't Count represents such a use of a book's title. This book is 
involved in litigation currently pending before the Commission. Simon &: Schuster, 
Inc., TRADE REG. REP. (Transfer Binder 1963-65) ,I 16559 (FTC 1963) (pending). 
25. Should the courts find that the publisher's advertising representations are 
protected by the first amendment in cases like Rodale Press, they will likely reject 
a construction of the Federal Trade Commission Act which gives it an unconstitu-
tional application, and they hold instead that the Commission does not have authority 
to proceed under the act itself. Cf. Scientific Mfg. Co. v. FTC, 124 F.2d 640, 644 (3d 
Cir. 1941). 
26. See notes 5, 6, &: 20 supra. For example, if an author falsely states in his 
preface that his book is "medically endorsed" and this phrase appears in the adver• 
tisement, it can be enjoined because it is not a representation of the ideas of the 
author. 
